Risk factors and evolution of Ventilator-associated pneumonia by Staphylococcus aureus sensitive or resistant to oxacillin in patients at the intensive care unit of a Brazilian University Hospital

This study investigated the participation and risk factors of VAP by resistant (ORSA) or sensitive (OSSA) S. aureus to oxacillin and evaluated the implications of adequate or inadequate empirical antimicrobial therapeutics in its evolution in patients interned in a mixing ICU of adults. A patient co...

Full description

Bibliographic Details
Main Authors: Michel R. Moreira, Renata L. Cardoso, Alair B. Almeida, Paulo P. Gontijo Filho
Format: Article
Language:English
Published: Elsevier
Series:Brazilian Journal of Infectious Diseases
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702008000600011&lng=en&tlng=en
_version_ 1818791639130308608
author Michel R. Moreira
Renata L. Cardoso
Alair B. Almeida
Paulo P. Gontijo Filho
author_facet Michel R. Moreira
Renata L. Cardoso
Alair B. Almeida
Paulo P. Gontijo Filho
author_sort Michel R. Moreira
collection DOAJ
description This study investigated the participation and risk factors of VAP by resistant (ORSA) or sensitive (OSSA) S. aureus to oxacillin and evaluated the implications of adequate or inadequate empirical antimicrobial therapeutics in its evolution in patients interned in a mixing ICU of adults. A patient control-case study with PAVs by ORSA and OSSA was carried out from May 2005 to April 2007 involving 993 patients. VAP was defined based on clinical, radiological, and microbiological (> 106 CFU/mL count in the tracheal aspirate) criteria. Four hundred and seventy four (47.7%) patients were submitted to mechanical ventilation with 141 (29.7%) VAPs, with S. aureus as the most frequent agent (41.2%). The phenotype ORSA accounted for 47.5% and OSSA for 52.5%, predominant in late-onset VAPs with frequencies of 93.1% and 68.7%, respectively. Age > 60, use of corticoid and previous antibiotic therapy were related (p<0.05) with the development of VAP by ORSA. Mortality rate was higher (p>0.05) in the group with VAP by ORSA (37.9%). S. aureus was the main agent of VAPs, around half by ORSA, associated with age, late-onset VAP development and previous use of antibiotics and corticoids, but with no significant difference in mortality compared with VAP by OSSA.
first_indexed 2024-12-18T15:14:33Z
format Article
id doaj.art-e1911561a73544628b40240209b8741c
institution Directory Open Access Journal
issn 1678-4391
language English
last_indexed 2024-12-18T15:14:33Z
publisher Elsevier
record_format Article
series Brazilian Journal of Infectious Diseases
spelling doaj.art-e1911561a73544628b40240209b8741c2022-12-21T21:03:33ZengElsevierBrazilian Journal of Infectious Diseases1678-439112649950310.1590/S1413-86702008000600011S1413-86702008000600011Risk factors and evolution of Ventilator-associated pneumonia by Staphylococcus aureus sensitive or resistant to oxacillin in patients at the intensive care unit of a Brazilian University HospitalMichel R. Moreira0Renata L. Cardoso1Alair B. Almeida2Paulo P. Gontijo Filho3Universidade Federal de UberlândiaUniversidade Federal de UberlândiaUniversidade Federal de UberlândiaUniversidade Federal de UberlândiaThis study investigated the participation and risk factors of VAP by resistant (ORSA) or sensitive (OSSA) S. aureus to oxacillin and evaluated the implications of adequate or inadequate empirical antimicrobial therapeutics in its evolution in patients interned in a mixing ICU of adults. A patient control-case study with PAVs by ORSA and OSSA was carried out from May 2005 to April 2007 involving 993 patients. VAP was defined based on clinical, radiological, and microbiological (> 106 CFU/mL count in the tracheal aspirate) criteria. Four hundred and seventy four (47.7%) patients were submitted to mechanical ventilation with 141 (29.7%) VAPs, with S. aureus as the most frequent agent (41.2%). The phenotype ORSA accounted for 47.5% and OSSA for 52.5%, predominant in late-onset VAPs with frequencies of 93.1% and 68.7%, respectively. Age > 60, use of corticoid and previous antibiotic therapy were related (p<0.05) with the development of VAP by ORSA. Mortality rate was higher (p>0.05) in the group with VAP by ORSA (37.9%). S. aureus was the main agent of VAPs, around half by ORSA, associated with age, late-onset VAP development and previous use of antibiotics and corticoids, but with no significant difference in mortality compared with VAP by OSSA.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702008000600011&lng=en&tlng=enVentilator-associated pneumoniaHospital infectionStaphylococcus aureusResistant microorganisms
spellingShingle Michel R. Moreira
Renata L. Cardoso
Alair B. Almeida
Paulo P. Gontijo Filho
Risk factors and evolution of Ventilator-associated pneumonia by Staphylococcus aureus sensitive or resistant to oxacillin in patients at the intensive care unit of a Brazilian University Hospital
Brazilian Journal of Infectious Diseases
Ventilator-associated pneumonia
Hospital infection
Staphylococcus aureus
Resistant microorganisms
title Risk factors and evolution of Ventilator-associated pneumonia by Staphylococcus aureus sensitive or resistant to oxacillin in patients at the intensive care unit of a Brazilian University Hospital
title_full Risk factors and evolution of Ventilator-associated pneumonia by Staphylococcus aureus sensitive or resistant to oxacillin in patients at the intensive care unit of a Brazilian University Hospital
title_fullStr Risk factors and evolution of Ventilator-associated pneumonia by Staphylococcus aureus sensitive or resistant to oxacillin in patients at the intensive care unit of a Brazilian University Hospital
title_full_unstemmed Risk factors and evolution of Ventilator-associated pneumonia by Staphylococcus aureus sensitive or resistant to oxacillin in patients at the intensive care unit of a Brazilian University Hospital
title_short Risk factors and evolution of Ventilator-associated pneumonia by Staphylococcus aureus sensitive or resistant to oxacillin in patients at the intensive care unit of a Brazilian University Hospital
title_sort risk factors and evolution of ventilator associated pneumonia by staphylococcus aureus sensitive or resistant to oxacillin in patients at the intensive care unit of a brazilian university hospital
topic Ventilator-associated pneumonia
Hospital infection
Staphylococcus aureus
Resistant microorganisms
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702008000600011&lng=en&tlng=en
work_keys_str_mv AT michelrmoreira riskfactorsandevolutionofventilatorassociatedpneumoniabystaphylococcusaureussensitiveorresistanttooxacillininpatientsattheintensivecareunitofabrazilianuniversityhospital
AT renatalcardoso riskfactorsandevolutionofventilatorassociatedpneumoniabystaphylococcusaureussensitiveorresistanttooxacillininpatientsattheintensivecareunitofabrazilianuniversityhospital
AT alairbalmeida riskfactorsandevolutionofventilatorassociatedpneumoniabystaphylococcusaureussensitiveorresistanttooxacillininpatientsattheintensivecareunitofabrazilianuniversityhospital
AT paulopgontijofilho riskfactorsandevolutionofventilatorassociatedpneumoniabystaphylococcusaureussensitiveorresistanttooxacillininpatientsattheintensivecareunitofabrazilianuniversityhospital